InovaMED_Piemonte

Il modello di telemonitoraggio asincrono in Regione Piemonte. Dal modello sperimentale alla generalizzazione per il SSR

Principal investigator: Valeria D. Tozzi (CeRGAS)

Team UB/Cergas: Lucia Ferrara

Partners: Azienda Zero, Rete Oncologica del Piemonte e della Valle d’Aosta (ROP)

Sponsor: Roche S.p.A.

Duration: November 2023-December 2024

Abstract:

The Piedmont Region initiated a pilot project named "InovaMED" in 2022, aiming to establish an asynchronous telemonitoring model for chronic patients. Through the InovaMED platform, medical reports, opinions, images, chat messages, and video consultations could be exchanged, enabling real-time updates for both patients and doctors regarding their health conditions. The pilot phase experienced varying levels of engagement across different contexts and Local Health Authorities (LHAs).

Building upon this pilot experience, the overarching research objective is to create a reference model for asynchronous telemonitoring, extending the pilot to all LHAs in the region. Achieving this objective involves two sub-goals:
 

  • Understand and Represent: Explore the contents, processes, and initiation conditions within the experimenting realities.
  • Develop Model Extension Strategy: Generalize the pilot experience by designing an extension strategy and sharing it with other LHAs.

Due to the experimental nature, the research will focus on two conditions: breast cancer and lung cancer.
The project is structured into four main research steps:
 

  1. Analysis of the Experimental Model: analyze the pilot experience, design a research project, and align with various stakeholders. This includes defining research design, timing, methods, outputs, and communication. Methods will involve desk analysis of InovaMED's documentation and interviews with key informants.
     
  2. Representation of the Experimental Model: conduct a process and outcome evaluation, using a realistic evaluation approach to highlight distinctive elements of the InovaMED project, contextual factors, mechanisms, enabling factors, and barriers to implementation. Multiple qualitative case studies will be conducted.
     
  3. Development and Diffusion Strategy of the Regional Asynchronous Telemonitoring Model: identify transferability and generalization elements, especially for breast and lung cancers, and design a strategy for extension and sharing with other LHAs. Workshops will include LHAs, Azienda Zero, the Regional Oncological Cancer network (ROP), and regional representatives.
     
  4. Dissemination: a final document and a scientific journal article will be generated, outlining project results and the method adopted for defining the framework and prototype to extend the experimental model and implementation strategy.

In summary, the project focuses on understanding the local context of a pilot project and creating a scalable model for broader regional implementation. The research uses a comprehensive approach, involving analysis, representation, strategy development, and knowledge dissemination, contributing valuable insights to healthcare innovation.